Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 11 studies | 64% ± 23% | |
| oligodendrocyte precursor cell | 11 studies | 43% ± 15% | |
| GABAergic neuron | 10 studies | 54% ± 27% | |
| interneuron | 6 studies | 55% ± 31% | |
| retinal ganglion cell | 6 studies | 42% ± 20% | |
| neuron | 4 studies | 35% ± 13% | |
| astrocyte | 4 studies | 33% ± 20% | |
| endothelial cell | 3 studies | 48% ± 15% | |
| GABAergic interneuron | 3 studies | 65% ± 6% | |
| ON-bipolar cell | 3 studies | 37% ± 15% | |
| amacrine cell | 3 studies | 49% ± 12% | |
| glycinergic amacrine cell | 3 studies | 43% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 14 studies | 41% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 93% | 1248.90 | 2463 / 2642 | 59% | 2.51 | 417 / 705 |
| pancreas | 99% | 550.06 | 325 / 328 | 13% | 0.23 | 24 / 178 |
| thymus | 88% | 301.95 | 575 / 653 | 6% | 0.15 | 36 / 605 |
| kidney | 43% | 139.17 | 38 / 89 | 49% | 2.23 | 443 / 901 |
| lung | 82% | 304.09 | 473 / 578 | 3% | 0.07 | 30 / 1155 |
| adrenal gland | 16% | 38.33 | 42 / 258 | 44% | 2.58 | 102 / 230 |
| blood vessel | 59% | 211.97 | 786 / 1335 | 0% | 0 | 0 / 0 |
| uterus | 24% | 43.76 | 40 / 170 | 2% | 0.06 | 7 / 459 |
| adipose | 20% | 32.95 | 237 / 1204 | 0% | 0 | 0 / 0 |
| skin | 18% | 38.85 | 328 / 1809 | 0% | 0.01 | 1 / 472 |
| heart | 12% | 18.39 | 104 / 861 | 0% | 0 | 0 / 0 |
| intestine | 3% | 3.35 | 32 / 966 | 5% | 0.09 | 27 / 527 |
| breast | 7% | 10.18 | 33 / 459 | 0% | 0.01 | 4 / 1118 |
| prostate | 4% | 5.18 | 11 / 245 | 2% | 0.05 | 11 / 502 |
| bladder | 0% | 0 | 0 / 21 | 5% | 0.10 | 23 / 504 |
| stomach | 0% | 0.25 | 1 / 359 | 4% | 0.12 | 12 / 286 |
| ovary | 2% | 1.98 | 4 / 180 | 0% | 0 | 0 / 430 |
| esophagus | 1% | 0.98 | 13 / 1445 | 1% | 0.02 | 2 / 183 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.01 | 3 / 406 |
| muscle | 0% | 0.44 | 2 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
| GO_0042995 | Cellular component | cell projection |
| GO_0043235 | Cellular component | receptor complex |
| GO_0042734 | Cellular component | presynaptic membrane |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | KCTD16 |
| Protein name | BTB/POZ domain-containing protein KCTD16 (Potassium channel tetramerization domain-containing protein 16) |
| Synonyms | KIAA1317 |
| Description | FUNCTION: Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity). . |
| Accessions | Q68DU8 ENST00000507359.3 ENST00000512467.6 |